GP Strategies Corp.

GP Strategies Corp.

GP Strategies Corp.

Overview
Date Founded

1959

Headquarters

70 Corporate Center,11000 Broken Land Parkway,Suite 200,Columbia, MD 21044

Type of Company

Public

Employees (Worldwide)

4,689

Industries

Management Consulting
Consumer Services
Human Resources & Personnel Services
Computer Software
Other Business & Consulting Services
IT Consulting & Services
Holding Companies
Engineering, Construction & Architecture

Company Description

GP Strategies Corp. provides training, e-Learning solutions, management consulting and engineering services. It operates through the following segments: Learning Solutions, Professional & Technical Services, Sandy Training & Marketing, and Performance Readiness Solutions. The Learning Solutions segment delivers training, curriculum design and development, e-Learning services, system hosting, training business process outsourcing and consulting services to companies in the electronics and semiconductors, healthcare, software, financial and other industries as well as to government agencies. The Professional & Technical Services segment provides training, consulting, engineering and technical services, including lean consulting, emergency preparedness, safety and regulatory compliance, chemical demilitarization and environmental services to large companies in the manufacturing, steel, pharmaceutical and petrochemical industries, federal and state government agencies and large government contractors. The Sandy Training & Marketing segment provides custom product sales training. The Performance Readiness Solutions provides performance consulting and technology consulting services, including platform adoption, end-user training, change management, knowledge management, customer product training outsourcing and sales enablement solutions in industries such as manufacturing, aerospace, healthcare, life sciences, consumer products, financial, telecommunications, services and higher education as well as the public sector. The company was founded in 1959 and is headquartered in Columbia, MD.

Contact Data
Trying to get in touch with decision makers at GP Strategies Corp.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chairman & Chief Executive Officer

President

Executive Vice President & Chief Financial Officer

Executive Vice President, General Counsel & Secretary

Chief Sales Officer

Executive Vice President & Chief of Staff

Executive Vice President-Learning Solutions Group

President Emeritus

Senior Client Partner

Senior Project Lead

Board of Directors

Chairman & Chief Executive Officer at GP Strategies Corp.

Former Chairman, President & Chief Executive Officer at Continucare Corp.

Managing Member at St. Cloud Capital II LLC

Director at New York University - The Center for Urban Science and Progress

Former Chief Executive Officer at Deloitte Central Europe Holdings Ltd.

Strategic Talent Advisor at Atlantic Bridge Ventures

Managing Partner at Portag3 Ventures

Paths to GP Strategies Corp.
Potential Connections via
Relationship Science
You
GP Strategies Corp.
Owners & Shareholders
Details Hidden

Sagard Capital Partners seeks to acquire significant minority positions in publicly-traded small-cap companies. They purchase equity in the open market, directly negotiate minority equity or debt positions and sponsor management teams in take-private transactions. Sagard pursues initiatives that drive long term value, even at the expense of short term results. The firm has no pre-determined holding period, no quarterly return targets and no external pressure to sell investments. Though not limited by sector, Sagard Capital Partners tends to invest in the stocks of small-cap US and Canadian companies in the electronic technology, retail, producer manufacturing and commercial services sectors. The firm maintains a high turnover rate.

Details Hidden

CSC uses the fundamental analysis method in formulating their investment advice and/or managing client assets. They attempt to measure the intrinsic value of a security by looking at economic and financial factors which include, but are not limited to, the overall economy, industry conditions, and the financial condition and management of the company itself to assess in our opinion if a security is underpriced relative to its market value. If the firm assesses that the company is underpriced relative to their estimate of intrinsic value, they are potential buyers. If it is overpriced, the firm will not make a purchase or may sell the security if they own it. CSC uses the following investment strategies in managing client accounts: small cap value; small cup plus; small cap focus; all cap value; and strategic value.

Details Hidden

Rutabaga Capital Management (RCM) provides investment advice primarily related to common stock of companies with micro and small market capitalizations. They define companies that have micro capitalizations to have a market capitalization less than $300 million. They define companies that have small capitalizations to have a market capitalization between $300 million and $1.5 billion. RCM invests primarily in common stock equity securities issued by US issuers. Portfolios are relatively fully invested at all times. Virtually all of the same securities are held across all institutional accounts within the respective strategies, micro-cap and small-cap. RCM utilizes a fundamental, bottom-up company-specific approach that emphasizes identifying companies with strong market shares (usually #1 or #2 in their markets).

Recent Transactions
Details Hidden

Bright Horizons Family Solutions, Inc. purchases Gp Strategies Corp. /Tuition Program Management Bus from GP Strategies Corp.

Details Hidden

GP Strategies Corp. purchases TTi Global, Inc.

Details Hidden

GP Strategies Corp. purchases TTI (Europe) Ltd. from Berkshire Hathaway, Inc.

Transaction Advisors
Legal Advisor

Advised onGP Strategies Corp. purchases Performtech, Inc.

Legal Advisor

Advised onGP Strategies Corp., GP Strategies Training Ltd. purchase Youtrain Ltd.

Legal Advisor

Advised onGP Strategies Corp. purchases McKinney Rogers International Ltd.

Legal Advisor

Advised onGP Strategies Corp. purchases Performtech, Inc.

Advisors & Consultants
Advisor

Former Executive Vice President & Chief Financial Officer at GP Strategies Corp.

Advisor

Former Head, Business Transformation Services at GP Strategies Corp.

Advisor

Former Executive Vice President-Professional & Technical Services at GP Strategies Corp.

Clients

Bank of America Corp. is a bank and financial holding company, which engages in the provision of banking and nonbank financial services. It operates through the following segments: Consumer Banking, Global Wealth and Investment Management, Global Banking, Global Markets, and All Other. The Consumer Banking segment offers credit, banking, and investment products and services to consumers and small businesses. The Global Wealth and Investment Management provides client experience through a network of financial advisors focused on to meet their needs through a full set of investment management, brokerage, banking, and retirement products. The Global Banking segment deals with lending-related products and services, integrated working capital management and treasury solutions to clients, and underwriting and advisory services. The Global Markets segment includes sales and trading services, as well as research, to institutional clients across fixed-income, credit, currency, commodity, and equity businesses. The All Other segment consists of asset and liability management activities, equity investments, non-core mortgage loans and servicing activities, the net impact of periodic revisions to the mortgage servicing rights (MSR) valuation model for both core and non-core MSRs, other liquidating businesses, residual expense allocations and other. The company was founded by Amadeo Peter Giannini in 1904 is headquartered in Charlotte, NC.

Merck & Co., Inc. , d.b.a. Merck Sharp & Dohme, MSD outside the United States and Canada, is an American pharmaceutical company and is one of the largest pharmaceutical companies in the world.

Lockheed Martin Corp. operates as a global security and aerospace company, which engages in the research, design, development, manufacture, integration, and sustainment of technology systems, products, and services. It operates through the following business segments: Aeronautics, Missiles and Fire Control (MFC), Rotary and Mission Systems (RMS) and Space. The Aeronautics segment researches, designs, develops, manufactures, integrates, sustains, supports, and upgrades advanced military aircraft, including combat and air mobility aircraft, unmanned air vehicles, and related technologies. The MFC segment provides air and missile defence systems; tactical missiles and air-to-ground precision strike weapon systems; logistics; fire control systems; mission operations support, readiness, engineering support and integration services; manned and unmanned ground vehicles; and energy management solutions. The RMS segment offers design, manufacture, service, and support for a variety of military and commercial helicopters; ship and submarine mission and combat systems; mission systems and sensors for rotary and fixed-wing aircraft; sea and land-based missile defence systems; radar systems; the Littoral Combat Ship; simulation and training services; and unmanned systems and technologies. The Space segment comprises of the research and development, design, engineering and production of satellites, strategic, and defensive missile systems and space transportation systems. The company was founded in 1961 and is headquartered in Bethesda, MD.

Key Stats and Financials As of 2018
Market Capitalization
$201M
Total Enterprise Value
$314M
Earnings Per Share
$0.59
Revenue
$515M
Net Profit
$9.84M
Total Debt
$116M
Total Equity
$187M
Enterprise Value Sales
0.61x
TEVNet Income
31.88x
Debt TEV
0.37x
EBITDAMargin
4.83%
Enterprise Value EBITDAOperating
12.6x
EBITDA
$24.9M
Three Year Compounded Annual Growth Rate Of Revenue
1.66%
Five Year Compounded Annual Growth Rate Of Revenue
3.36%
Investments
Details Hidden

Valera Pharmaceuticals, Inc. develops and commercializes products for the treatment of urology and endocrine conditions, diseases and disorders. The Company was founded in 1972 and is located in Cranbury, NJ.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by GP Strategies Corp.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of GP Strategies Corp.'s profile does not indicate a business or promotional relationship of any kind between RelSci and GP Strategies Corp..